204 related articles for article (PubMed ID: 2554337)
1. Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule.
Wessels MR; Rubens CE; Benedí VJ; Kasper DL
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8983-7. PubMed ID: 2554337
[TBL] [Abstract][Full Text] [Related]
2. Identification of a genetic locus essential for capsule sialylation in type III group B streptococci.
Wessels MR; Haft RF; Heggen LM; Rubens CE
Infect Immun; 1992 Feb; 60(2):392-400. PubMed ID: 1309720
[TBL] [Abstract][Full Text] [Related]
3. Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence.
Rubens CE; Wessels MR; Heggen LM; Kasper DL
Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7208-12. PubMed ID: 2823254
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of two group B streptococcal virulence factors.
Rubens CE; Wessels MR; Kuypers JM; Kasper DL; Weiser JN
Semin Perinatol; 1990 Aug; 14(4 Suppl 1):22-9. PubMed ID: 2173147
[TBL] [Abstract][Full Text] [Related]
5. Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression.
Chaffin DO; Mentele LM; Rubens CE
J Bacteriol; 2005 Jul; 187(13):4615-26. PubMed ID: 15968073
[TBL] [Abstract][Full Text] [Related]
6. Characterization of cpsF and its product CMP-N-acetylneuraminic acid synthetase, a group B streptococcal enzyme that can function in K1 capsular polysaccharide biosynthesis in Escherichia coli.
Haft RF; Wessels MR; Mebane MF; Conaty N; Rubens CE
Mol Microbiol; 1996 Feb; 19(3):555-63. PubMed ID: 8830246
[TBL] [Abstract][Full Text] [Related]
7. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci.
Marques MB; Kasper DL; Pangburn MK; Wessels MR
Infect Immun; 1992 Oct; 60(10):3986-93. PubMed ID: 1398910
[TBL] [Abstract][Full Text] [Related]
8. Growth of group B streptococci in human serum leads to increased cell surface sialic acid and decreased activation of the alternative complement pathway.
Platt MW; Correa N; Mold C
Can J Microbiol; 1994 Feb; 40(2):99-105. PubMed ID: 8019940
[TBL] [Abstract][Full Text] [Related]
9. Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci).
von Hunolstein C; D'Ascenzi S; Wagner B; Jelínková J; Alfarone G; Recchia S; Wagner M; Orefici G
Infect Immun; 1993 Apr; 61(4):1272-80. PubMed ID: 8454331
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of a region of the group B streptococcus chromosome involved in type III capsule expression.
Kuypers JM; Heggen LM; Rubens CE
Infect Immun; 1989 Oct; 57(10):3058-65. PubMed ID: 2550369
[TBL] [Abstract][Full Text] [Related]
11. Capsular polysaccharide regulates neutrophil complement receptor interactions with type III group B streptococci.
Edwards MS; Wessels MR; Baker CJ
Infect Immun; 1993 Jul; 61(7):2866-71. PubMed ID: 8514389
[TBL] [Abstract][Full Text] [Related]
12. Fisher scientific award lecture - the capsular polysaccharides of Group B Streptococcus and Streptococcus suis differently modulate bacterial interactions with dendritic cells.
Segura M
Can J Microbiol; 2012 Mar; 58(3):249-60. PubMed ID: 22356626
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant.
DeShazer D; Waag DM; Fritz DL; Woods DE
Microb Pathog; 2001 May; 30(5):253-69. PubMed ID: 11373120
[TBL] [Abstract][Full Text] [Related]
14. Virulence properties of type VII Streptococcus agalactiae (group B streptococci) and immunochemical analysis of capsular type polysaccharide.
VON Hunolstein C; Parisi L; Tissi L; Recchia S; Alfarone G; Nicolini L; Volpe C; Wagner B; Motlova J; Orefici G
J Med Microbiol; 1999 Nov; 48(11):983-990. PubMed ID: 10535641
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of type IV group B Streptococcus capsular polysaccharide.
Wessels MR; Benedí WJ; Jennings HJ; Michon F; DiFabio JL; Kasper DL
Infect Immun; 1989 Apr; 57(4):1089-94. PubMed ID: 2494110
[TBL] [Abstract][Full Text] [Related]
16. Effect of type III group B streptococcal capsular polysaccharide on invasion of respiratory epithelial cells.
Hulse ML; Smith S; Chi EY; Pham A; Rubens CE
Infect Immun; 1993 Nov; 61(11):4835-41. PubMed ID: 8406885
[TBL] [Abstract][Full Text] [Related]
17. Sialylation of Streptococcus suis serotype 2 is essential for capsule expression but is not responsible for the main capsular epitope.
Lecours MP; Fittipaldi N; Takamatsu D; Okura M; Segura M; Goyette-Desjardins G; Van Calsteren MR; Gottschalk M
Microbes Infect; 2012 Sep; 14(11):941-50. PubMed ID: 22521569
[TBL] [Abstract][Full Text] [Related]
18. The serotype of type Ia and III group B streptococci is determined by the polymerase gene within the polycistronic capsule operon.
Chaffin DO; Beres SB; Yim HH; Rubens CE
J Bacteriol; 2000 Aug; 182(16):4466-77. PubMed ID: 10913080
[TBL] [Abstract][Full Text] [Related]
19. Role of group B streptococcal capsular polysaccharides in the induction of septic arthritis.
Tissi L; von Hunolstein C; Bistoni F; Marangi M; Parisi L; Orefici G
J Med Microbiol; 1998 Aug; 47(8):717-23. PubMed ID: 9877193
[TBL] [Abstract][Full Text] [Related]
20. Capsular type-specific polysaccharide partially inhibits group B Streptococcus-induced pulmonary hypertension.
Li JX; Gray BM; Pritchard DG; Oliver JR; Grantham KD; Philips JB
Am Rev Respir Dis; 1993 Jul; 148(1):152-7. PubMed ID: 8317791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
